AHRQ seeks comment on glaucoma questions
This article was originally published in The Gray Sheet
Executive SummaryAgency for Healthcare Research and Quality is taking comments through May 20 on key questions for research into the comparative effectiveness of screening approaches and treatments for glaucoma. For example, the agency's Effective Health Care Program will examine the value of screening tests as well as laser and surgical treatments for open-angle glaucoma. Questions include whether medical, laser and other surgical treatments for open-angle glaucoma prevent or slow the progression of optic nerve damage and visual field loss, as well as what harms are associated with screening or treatment
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.